Vascular lesions of the female genital tract: Clinicopathologic findings and application of the ISSVA classification

2017 ◽  
Vol 24 (3) ◽  
pp. 161-167 ◽  
Author(s):  
Georgia Karpathiou ◽  
Celine Chauleur ◽  
Vanessa Da Cruz ◽  
Fabien Forest ◽  
Michel Peoc’h
Keyword(s):  
Genital Tract ◽  
Female Genital Tract ◽  
Vascular Lesions ◽  
Clinicopathologic Findings ◽  
Female Genital ◽  
Issva Classification

Benign vascular tumors of female genital tract

2006 ◽  
Vol 16 (3) ◽  
pp. 1195-1200 ◽  
Author(s):  
R. Gupta ◽  
S. Singh ◽  
S. Nigam ◽  
N. Khurana
Keyword(s):  
Genital Tract ◽  
Female Genital Tract ◽  
Special Problem ◽  
Vascular Lesions ◽  
Vascular Tumors ◽  
Pregnancy Risk ◽  
Duration Of Symptoms ◽  
Clinical Diagnoses ◽  
Microscopic Features ◽  
Female Genital

Vascular tumors are rare in female genital tract (FGT). The aim of this study was to analyze the distribution of vascular tumors in FGT and to highlight their clinicopathologic features. As a retrospective study, clinical features including imaging studies, gross findings, and microscopic features of cases (ten) diagnosed as having vascular tumors of FGT over 4 years were reviewed. The age range of our cases was 12–52 years. The presenting complaint was abdominal pain/mass, postcoital bleeding, and vaginal and vulval mass. In most cases, duration of symptoms was 6 months to 2 years. Only one case had a long-standing history of 8 years. The vascular tumors occurred most commonly in ovary (six), followed by vulva (two), and one each in cervix and vagina. Clinical diagnoses ranged from cystadenoma in ovarian tumors to endocervical polyp in cervical tumor. Histologically, all were benign vascular neoplasms, ranging from hemangioma (five), lymphangioma (one), lymphangioma circumscriptum (one) to angiomatosis (two) and arteriovenous malformation (one). Thus, we conclude that vascular lesions in FGT can present with symptoms similar to epithelial malignancies and may lead to unwarranted radical surgery. Vascular lesions of cervix and vulvovaginal region pose special problem during pregnancy. Risk of Kasabach–Merritt coagulopathy has to be considered in larger vascular tumors. Most of these cases can be treated by surgery.

Biopsy of Lesions of the Female Genital Tract in the Ambulatory Setting

2004 ◽  
Vol 14 (3) ◽  
pp. 185-200 ◽  
Author(s):  
William Paul Irvin ◽  
Peyton T. Taylor
Keyword(s):  
Genital Tract ◽  
Female Genital Tract ◽  
Ambulatory Setting ◽  
Female Genital

PRIMARY LYMPHOMAS OF THE FEMALE GENITAL TRACT

2017 ◽  
Author(s):  
Sakhri Saida
Keyword(s):  
Genital Tract ◽  
Female Genital Tract ◽  
Female Genital

scholarly journals Cervical Mesonephric Adenocarcinoma: A Case Report of a Rare Gynecological Tumor from Embryological Remains of the Female Genital Tract

2021 ◽  
Author(s):  
Catarina Reis-de-Carvalho ◽  
Carolina Vaz-de-Macedo ◽  
Santiago Ortiz ◽  
Anabela Colaço ◽  
Carlos Calhaz-Jorge
Keyword(s):  
Case Report ◽  
Genital Tract ◽  
Female Genital Tract ◽  
Treatment Protocol ◽  
Gynecology And Obstetrics ◽  
Mesonephric Adenocarcinoma ◽  
Gynecological Tumor ◽  
Cervical Adenocarcinomas ◽  
Female Genital

Abstract Introduction Malignant mesonephric tumors are uncommon in the female genital tract, and they are usually located where embryonic remnants of Wolffian ducts are detected, such as the uterine cervix. The information about these tumors, their treatment protocol, and prognosis are scarce. Case report A 60-year-old woman with postmenopausal vaginal bleeding was initially diagnosed with endometrial carcinoma. After suspicion co-testing, the patient underwent a loop electrosurgical excision of the cervix and was eventually diagnosed with mesonephric adenocarcinoma. She was subjected to a radical hysterectomy, which revealed International Federation of Gynecology and Obstetrics (FIGO) IB1 stage, and adjuvant radiotherapy. The follow-up showed no evidence of recurrence after 60 months. Conclusion We present the case of a woman with cervical mesonephric adenocarcinoma. When compared with the literature, this case had the longest clinical follow-up without evidence of recurrence, which reinforces the concept that these tumors are associated with a favorable prognosis if managed according to the guidelines defined for the treatment of patients with cervical adenocarcinomas. Though a rare entity, it should be kept in mind as a differential diagnosis for other cervical cancers.

Sign in / Sign up

Export Citation Format

Share Document